SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000886163-03-000002
Filing Date
2003-01-13
Accepted
2003-01-13 13:26:57
Documents
12

Document Format Files

Seq Description Document Type Size
1 LIGAND FORM S-3 ligands30103.txt S-3 217994
3 EXHIBIT 1.1 - PURCHASE AGREEMENT ex11.txt EX-1 100414
4 EXHIBIT 4.2 - REG. RIGHTS AGREEMENT ex42.txt EX-4 68522
5 EXHIBIT 4.3 - INDENTURE ex43.txt EX-4 238026
6 EXHIBIT 4.4 - 6% CONVERTIBLE SUBORDINATED NOTE ex44.txt EX-4 36314
7 EXHIBIT 4.5 - PLEDGE AGREEMENT ex45.txt EX-4 117941
8 EXHIBIT 4.6 - CONTROL AGREEMENT ex46.txt EX-4 24298
9 EXHIBIT 5.1 - LEGAL OPINION ex51.txt EX-5 3343
10 EXHIBIT 12.1 - RATIO OF EARNINGS ex121.txt EX-12 4369
11 EXHIBIT 23.1 - D&T CONSENT ex231.txt EX-23 750
12 EXHIBIT 23.2 - E&Y CONSENT ex232.txt EX-23 746
13 EXHIBIT 25.1 - FORM T-1 ex251.txt EX-25 11400
  Complete submission text file 0000886163-03-000002.txt   826955
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-102483 | Film No.: 03511958
SIC: 2834 Pharmaceutical Preparations